Healthcare -
Biotechnology - NASDAQ - US
$ 26.33
-8.8 %
$ 2.96 B
Market Cap
-26.07
P/E
VKTX - SHORT-TERM INVESTMENTS
Short-term Investments VKTX - Viking Therapeutics, Inc.
307 M
LAST VALUE
32.08%
2 YEAR CAGR
2.07%
5 YEAR CAGR
0.00%
10 YEAR CAGR